vaccination

CommuniVax Coalition Answers “Why Social Science”

The latest Why Social Science? post comes from a group of anthropologists on behalf of the CommuniVax Coalition, an alliance of social scientists, public health experts, and community advocates working to strengthen COVID-19 vaccination efforts in the United States, particularly in communities of color.

New SEAN Guidance Offers Strategies for Communicating About Vaccine Efficacy

The National Academies of Sciences, Engineering, and Medicine’s Societal Experts Action Network (SEAN) (see COSSA’s previous coverage) has published a new guidance on Understanding and Communicating Vaccine Efficacy and Effectiveness. The guidance is intended to help public officials prepare and evaluate their communications efforts around vaccination. It is available as an interactive web tool, with highlights on Communicating Vaccine Efficacy and on Communicating About Efficacy and Effectiveness in the Context of Equity in Covid-19 Vaccine Distribution, as well as a full report on the National Academies website.

House Science Committee Holds Hearing On COVID-19 Vaccines and Encouraging Uptake

On February 19, the House Committee on Science, Space and Technology held a hearing on “The Science of COVID-19 Vaccines and Encouraging Vaccine Uptake.” The Committee heard testimony from Professor in Vaccinology and Director at the Center for Vaccine Development and Global Health Dr. Kathleen Neuzil, Director and Health Authority at the Dallas County Department of Health and Human Services Dr. Philip Huang, Deputy Commissioner at the Oklahoma State Department of Health Keith Reed, and the Scientific Director at the Center for Health Incentives and Behavioral Economics and Associate Professor of Nursing and Health Policy at the University of Pennsylvania…

SEAN Releases New Expert Consultation on COVID-19 Vaccine Confidence

The National Academies of Sciences, Engineering, and Medicine’s Societal Experts Action Network (SEAN) (see COSSA’s previous coverage) has published a new rapid expert consultation, Building COVID-19 Vaccine Confidence. The guidance compiles research-backed strategies for effectively reaching vulnerable communities and skeptical populations to provide trustworthy information about the COVID-19 vaccine. The consultation is available as an interactive web tool, with highlights on Strategies for Public Engagement to Combat Mistrust and Build COVID-19 Vaccine Confidence and Communication Strategies for Promoting COVID-19 Vaccine Acceptance.  The report is also available as a full report on the National Academies website.

“Why Social Science?” Focuses on COVID-19 Vaccination

The latest Why Social Science? post comes from the authors of the recent National Institutes of Health (NIH) report “COVID-19 Vaccination Communication: Applying Behavioral and Social Science to Address Vaccine Hesitancy and Foster Vaccine Confidence,” who write about the evidence-informed best practices communities should use when sharing information about the vaccination process for COVID-19. Read it here and subscribe.

Vaccination Communication Report Authors Highlight Strategies to Reduce Hesitancy

During the January 14 COSSA Headlines webinar, Drs. Christine Hunter and Wen-Ying Sylvia Chou, two of the co-authors of the recent National Institutes of Health report on COVID-19 Vaccination Communication           , shared an overview of the report. They also provided a summary of the report’s recommendations that communities can utilize to ensure that messaging about the entire COVID-19 vaccination process relies on evidence-backed strategies. These are available as a one-page tip sheet. A recording of the webinar and the slides are posted to the COSSA website.

NIMHD Funding Research on Vaccine Hesitancy and Health Disparities

The National Institute on Minority Health and Health Disparities (NIMHD) within the National Institutes of Health (NIH) has released a Notice of Special Interest announcing a new funding opportunity for research on hesitancy to participate in vaccines among populations that experience health disparities. The notice seeks submissions on a variety of social and behavioral research questions including evaluating strategies to increase vaccination rates among target communities and methods to address barriers of receiving vaccines among health disparate communities, especially those with a higher risk of experiencing vaccine hesitancy. The first available due date for applications is February 5, 2021, with…

NIH Releases Report on COVID-19 Vaccine Communication

A panel of social and behavioral scientists coordinated by the National Institutes of Health (NIH) has released a report titled “COVID-19 Vaccination Communication: Applying Behavioral and Social Science to Address Vaccine Hesitancy and Foster Vaccine Confidence.” The report, led by the NIH Office of Behavioral and Social Sciences Research (OBSSR) and the National Cancer Institute (NCI), outlines research-based strategies to communicate the importance of receiving a COVID-19 vaccine while addressing the challenges of vaccine hesitancy and misinformation. The strategies laid out in this report are largely based on the fundamentals of communication research while including specific considerations for individuals at…

National Academies Study on COVID-19 Vaccine Allocation Releases Discussion Draft, Seeks Feedback (Short Turnaround)

The National Academies of Sciences, Engineering, and Medicine (NASEM) has released a discussion draft of a Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, part of a fast-track study initiated over the summer (see previous coverage). The discussion draft, released September 1, aims to identify priorities to inform allocation of a limited initial supply of COVID-19 vaccine, taking into account factors such as racial/ethnic inequities and groups at higher risk due to health status, occupation, or living conditions. Feedback will be collected during a public listening session on September 2 as well as through a written comment period closing on…

National Academies Launch Study on COVID-19 Vaccine Allocation

The National Academies of Sciences, Engineering, and Medicine has launched a fast-track study to develop a framework for planning the equitable distribution of vaccines against COVID-19. The study, which is sponsored by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), is responsible for producing a consensus report that considers the following questions: “What criteria should be used in setting priorities for equitable allocation of vaccine? How should the criteria be applied in determining the first tier of vaccine recipients? As more vaccine becomes available, what populations should be added successively to the priority…

Subscribe

Past Newsletters

Browse

Archive

Browse 40 years of the COSSA Washington Update.